Background. Pseudomonas aeruginosa (Pa) is the most important pathogen infecting the airways in individuals with cystic fibrosis. A key question is whether children with newly acquired Pa infection who are able to achieve sustained eradication after early antipseudomonal therapy demonstrate improved long-term health outcomes compared with those who are unable to achieve a sustained microbiologic response
AbstractBackgroundThe prognostic value of Pseudomonas aeruginosa serology for antibiotic therapy in ...
AbstractBackgroundPatient dependent parameters to predict the long-term success of early eradication...
BACKGROUND: Eradication of new infection of Pseudomonas aeruginosa is an important intervention in m...
Background. Pseudomonas aeruginosa (Pa) is the most important pathogen infecting the airways in indi...
The risk of pulmonary exacerbation following Pseudomonas aeruginosa (Pa) acquisition in children wit...
Patients with cystic fibrosis are more susceptible than members of the general population to lung in...
AbstractIn patients with cystic fibrosis (CF), treatment of new Pseudomonas aeruginosa (Pa) infectio...
Introduction: Patients with Cystic fibrosis (CF) are more susceptible to pathogens like P. aeruginos...
AbstractPseudomonas aeruginosa (Pa) is one of the most common and clinically important pathogens in ...
The Early Pseudomonal Infection Control (EPIC) randomized trial rigorously evaluated the efficacy of...
Background Pseudomonas aeruginosa (Pa) is a leading cause of lung infection in patients with cystic ...
AbstractBackgroundThis study was designed to address the concern that intensive regimens to eradicat...
Background. Pseudomonas aeruginosa is a key respiratory pathogen in people with cystic fibrosis (CF)...
BACKGROUND: While the emergence of chronic and mucoid Pseudomonas aeruginosa (Pa) infection are b...
ABSTRACT: When do infants and young children with cystic fibrosis acquire infection with Pseudomonas...
AbstractBackgroundThe prognostic value of Pseudomonas aeruginosa serology for antibiotic therapy in ...
AbstractBackgroundPatient dependent parameters to predict the long-term success of early eradication...
BACKGROUND: Eradication of new infection of Pseudomonas aeruginosa is an important intervention in m...
Background. Pseudomonas aeruginosa (Pa) is the most important pathogen infecting the airways in indi...
The risk of pulmonary exacerbation following Pseudomonas aeruginosa (Pa) acquisition in children wit...
Patients with cystic fibrosis are more susceptible than members of the general population to lung in...
AbstractIn patients with cystic fibrosis (CF), treatment of new Pseudomonas aeruginosa (Pa) infectio...
Introduction: Patients with Cystic fibrosis (CF) are more susceptible to pathogens like P. aeruginos...
AbstractPseudomonas aeruginosa (Pa) is one of the most common and clinically important pathogens in ...
The Early Pseudomonal Infection Control (EPIC) randomized trial rigorously evaluated the efficacy of...
Background Pseudomonas aeruginosa (Pa) is a leading cause of lung infection in patients with cystic ...
AbstractBackgroundThis study was designed to address the concern that intensive regimens to eradicat...
Background. Pseudomonas aeruginosa is a key respiratory pathogen in people with cystic fibrosis (CF)...
BACKGROUND: While the emergence of chronic and mucoid Pseudomonas aeruginosa (Pa) infection are b...
ABSTRACT: When do infants and young children with cystic fibrosis acquire infection with Pseudomonas...
AbstractBackgroundThe prognostic value of Pseudomonas aeruginosa serology for antibiotic therapy in ...
AbstractBackgroundPatient dependent parameters to predict the long-term success of early eradication...
BACKGROUND: Eradication of new infection of Pseudomonas aeruginosa is an important intervention in m...